Polygon Management »

Kempharm shares owned by Polygon Management

Quarter-by-quarter ownership of Kempharm (ZVRA) shares owned by Polygon Management from 13F filings

Historical chart of Polygon Management investment in Kempharm

Tip: Access up to 7 years of quarterly data

All positions including Kempharm held by Polygon Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kempharm by Polygon Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 193k 8.96

More positions owned by Polygon Management

Uipath Cl A (PATH)
Kolibri Global Energy Com New (KGEI)
Lyft Cl A Com (LYFT)
Autolus Therapeutics Spon Ads (AUTL)
Sprinklr Cl A (CXM)
Workiva Com Cl A (WK)
Annexon (ANNX)
Praxis Precision Medicines I Com New (PRAX)
Celldex Therapeutics Com New (CLDX)
Arrowhead Pharmaceuticals (ARWR)
Pharvaris N V (PHVS)
Axsome Therapeutics (AXSM)
Dyne Therapeutics (DYN)
Mbx Biosciences (MBX)
Rapt Therapeutics Com New (RAPT)

View all positions for Polygon Management

Top funds holding Kempharm

BlackRock
Woodline Partners
Vanguard Group
Caption Management
Adage Capital Partners GP
Nantahala Capital Management
FMR
State Street Corporation
Geode Capital Management
Legal & General Group
Millennium Management
683 Capital Management
Royce & Associates
D. E. Shaw & Co
Marshall Wace

View all funds holding Kempharm